The affected products are 10-millilter vials of testosterone injections with a strength of 200 milligrams/millileters. The recall, which is voluntary, was issued due to the presence of particulate matter in the vials.
The injections are used as a replacement therapy in males who are testosterone-deficient.
More articles on pharmacy:
Allergan sues Pfizer over costs related to opioid lawsuits
Teva’s revenue drops 18% in Q2
Who knew? There’s a trophy for ‘most hated’ pharma chief: 10 notes
